Neuronal α₂δ proteins and brain disorders.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alpha-2/delta (α₂δ) proteins are crucial glycoproteins in the nervous system, regulating voltage-gated calcium channels and neuronal function.
• These proteins are the targets of gabapentin and pregabalin, commonly used for neuropathic pain and epilepsy.
• Four human genes (CACNA2D1-4) encode the α₂δ-1 to α₂δ-4 isoforms.

Purpose of the Study:

• To review the disease associations of all known α₂δ genes.
• To hypothesize on the pathophysiological mechanisms underlying these associations.
• To identify key future research directions for α₂δ proteins in neurological and neuropsychiatric disorders.

Main Methods:

• Literature review of identified disease associations for CACNA2D1-4 genes.
• Analysis of known physiological roles of α₂δ proteins in neuronal function.
• Synthesis of current knowledge to propose pathophysiological mechanisms and future research questions.

Main Results:

• The α₂δ genes (CACNA2D1-4) have been implicated in epilepsy, autism spectrum disorders, bipolar disorder, schizophrenia, and depression.
• Dysregulation of α₂δ protein function is hypothesized to contribute to the pathophysiology of these diverse brain disorders.
• Understanding the specific roles of α₂δ isoforms in disease is critical.

Conclusions:

• Alpha-2/delta (α₂δ) proteins represent a significant link between genetic variations and a spectrum of neurological and neuropsychiatric disorders.
• Further research into the precise physiological and pathophysiological functions of α₂δ proteins is warranted.
• Elucidating these mechanisms may lead to novel therapeutic strategies for brain disorders.